"10.1371_journal.pone.0080151","plos one","2013-11-14T00:00:00Z","Chantale Montigny; Natalie Castellanos-Ryan; Robert Whelan; Tobias Banaschewski; Gareth J Barker; Christian Büchel; Jürgen Gallinat; Herta Flor; Karl Mann; Marie-Laure Paillère-Martinot; Frauke Nees; Mark Lathrop; Eva Loth; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Gunter Schumann; Michael N Smolka; Maren Struve; Trevor W Robbins; Hugh Garavan; Patricia J Conrod; and the IMAGEN Consortium","Department of Psychiatry, Université de Montréal, CHU Ste Justine Hospital, Montreal, Canada; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, United Kingdom; Central Institute of Mental Health, Mannheim, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Institute of Psychiatry, King’s College London, United Kingdom; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; Institut National de la Santé et de la Recherche Médicale, INSERM CEA Unit 1000 “Imaging & Psychiatry”, University Paris Sud, Orsay, France; AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France; Centre National de Génotypage, Evry, France; Rotman Research Institute, University of Toronto, Toronto, Canada; School of Psychology, University of Nottingham, United Kingdom; Montreal Neurological Institute, McGill University, Montreal, Canada; Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Germany; Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Germany; Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, University of Cambridge, United Kingdom; Mannheim Medical Faculty, University of Heidelberg, Germany; Hospital for Sick Children, University of Toronto, Toronto, Canada; Central Institute of Mental Health, Medical Faculty Mannheim / Heidelberg University, Department of Addictive Behaviour and Addiction Medicine, Manheim, Germany; Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont, United States of America","Conceived and designed the experiments: RW TB GJB CB JG KM MLPM FN ML EL TP ZP MR GS MNS MS TWR PJC HF. Performed the experiments: RW TB GJB CB JG KM MLPM FN ML EL TP ZP MR GS MNS MS TWR PJC HF. Analyzed the data: CM NCR PJC HG RW. Contributed reagents/materials/analysis tools: RW TB GJB CB JG KM MLPM FN ML EL TP ZP MR GS MNS MS TWR PJC HF. Wrote the manuscript: CM NCR PJC HG RW.","Gareth J. Barker received honoraria for teaching from General Electric during the course of this study. Trevor W. Robbins consults for Cambridge Cognition, E Lilly, GlaxoSmithKline, Merck Sharpe, Lundbeck and Dohme, Teva and Shire Pharmaceuticals, and has received recent research grants from Lilly, GSK and Lundbeck. Tobias Banaschewski served in an advisory or consultancy role for Bristol Myers-Squibb, Develco Pharma, Lilly, Medice, Novartis, Shire and Viforpharma and received conference attendance support and conference support or received speaker's fee from Lilly, Janssen McNeil, Medice, Novartis and Shire. He is/has been involved in clinical trials conducted by Lilly and Shire. The present work is unrelated to the Tobias Banaschewski's grants and relationships. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Chantale Montigny","CM",23,TRUE,19,19,5,5,TRUE,TRUE,TRUE,1,"23",TRUE
